Status:
COMPLETED
The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations
Lead Sponsor:
Ankara Training and Research Hospital
Conditions:
Bladder Cancer
Covid19
Eligibility:
All Genders
18-90 years
Brief Summary
In this study, investigators aim to reveal how the COVID-19 pandemic process affects primary bladder cancer presentations, tumor stages and degrees, the time elapsed between diagnosis and intervention...
Detailed Description
The rapid spread of the 2019 coronavirus disease (COVID-19) caused by a novel betacoronavirus known as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has had dramatic effects on indi...
Eligibility Criteria
Inclusion
- Primary bladder cancer
Exclusion
- Previous history of urinary tract tumor
- Chronic kidney disease
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2021
Estimated Enrollment :
183 Patients enrolled
Trial Details
Trial ID
NCT04900259
Start Date
July 1 2021
End Date
August 15 2021
Last Update
October 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Training and Research Hospital
Ankara, Altindag, Turkey (Türkiye), 06230